183 related articles for article (PubMed ID: 22585684)
1. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
Balsamo M; Vermi W; Parodi M; Pietra G; Manzini C; Queirolo P; Lonardi S; Augugliaro R; Moretta A; Facchetti F; Moretta L; Mingari MC; Vitale M
Eur J Immunol; 2012 Jul; 42(7):1833-42. PubMed ID: 22585684
[TBL] [Abstract][Full Text] [Related]
2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
4. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15.
Gong W; Xiao W; Hu M; Weng X; Qian L; Pan X; Ji M
Tissue Antigens; 2010 Dec; 76(6):467-75. PubMed ID: 20670353
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
7. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
8. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
9. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
10. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
11. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
12. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
13. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
[TBL] [Abstract][Full Text] [Related]
14. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
[TBL] [Abstract][Full Text] [Related]
16. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
[TBL] [Abstract][Full Text] [Related]
19. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
20. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
